# A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas

> **NCT02868892** · PHASE2 · TERMINATED · sponsor: **Western Regional Medical Center** · enrollment: 6 (actual)

## Conditions studied

- Adenocarcinoma of the Cervix
- Adenosquamous Cell Carcinoma of the Cervix

## Interventions

- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT02868892
- **Lead sponsor:** Western Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** departure of PI from institution and poor population for study participation
- **Last updated:** 2018-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02868892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02868892, "A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02868892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*